Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis

Analytical Biochemistry

Volumn 364, Issue 1, 2007, Pages 37-50

  Korekane, Hiroaki ^a,b   Tsuji, Satoyo ^a   Noura, Shingo ^a   Ohue, Masayuki ^a   Sasaki, Yo ^a   Imaoka, Shingi ^a   Miyamoto, Yasuhide ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b Japan Health Sciences Foundation   (Japan)

Author keywords

Colon cancer; Ganglioside; Mass spectrometry; Pyridylamination; Structure; Two dimensional mapping

Indexed keywords

ALKYLATION; ELECTROSPRAY IONIZATION; HISTOLOGY; MAPPING; MASS SPECTROMETRY; STRUCTURE (COMPOSITION); THIN LAYER CHROMATOGRAPHY; TISSUE;

COLON CANCER; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; GANGLIOSIDE; HIGH RESOLUTION ANALYSIS; METHYLATION ANALYSIS; PYRIDYLAMINATION; TWO DIMENSIONAL MAPPING; TWO-DIMENSIONAL HPLC;

TISSUE ENGINEERING;

ACYLSPHINGOSINE DEACYLASE; CARBOHYDRATE; FUCOGANGLIOSIDE DERIVATIVE; GANGLIOSIDE; GLYCOCERAMIDASE II; GLYCOSPHINGOLIPID; LACTONE DERIVATIVE; SULFATE; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; CANCER TISSUE; COLON ADENOCARCINOMA; ELECTROSPRAY MASS SPECTROMETRY; GLYCOBIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; METHYLATION; MICROANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY;

EID: 33947616186     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.01.034     Document Type: Article

References (26)

1. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Natl. Acad. Sci. USA 99 (2002) 10231-10233
2. Siddiqui B., Whitehead J.S., and Kim Y.S. Glycosphingolipids in human colonic adenocarcinoma. J. Biol. Chem. 253 (1978) 2168-2175
3. Portoukalian J., Zwingelstein G., and Dore J.F. Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur. J. Biochem. 94 (1979) 19-23
4. Magnani J.L., Nilsson B., Brockhaus M., Zopf D., Steplewski Z., Koprowski H., and Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J. Biol. Chem. 257 (1982) 14365-14369
5. Bolot G., David M.J., Kasama T., Taki T., Handa S., Richard M., Pignat J.C., Thomas L., and Portoukalian J. Occurrence of monosialosyl pentahexaosylceramide GalNAc-GM1 as specific tumor-associated ganglioside of human head and neck squamous cell carcinomas. Cancer Lett. 135 (1999) 159-164
6. Hamasaki H., Aoyagi M., Kasama T., Handa S., Hirakawa K., and Taki T. GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside. Biochim. Biophys. Acta 1437 (1999) 93-99
7. Ito A., Levery S.B., Saito S., Satoh M., and Hakomori S. A novel ganglioside isolated from renal cell carcinoma. J. Biol. Chem. 276 (2001) 16695-16703
8. Hakomori S., Nudelman E., Levery S.B., and Patterson C.M. Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosyl α2 leads to 6-galactosyl residue: A preliminary note. Biochem. Biophys. Res. Commun. 113 (1983) 791-798
9. Hakomori S., Nudelman E., Levery S.B., and Kannagi R. Novel fucolipids accumulating in human adenocarcinoma: I. Glycolipids with di- or trifucosylated type 2 chain. J. Biol. Chem. 259 (1984) 4672-4680
10. Fukushi Y., Hakomori S., Nudelman E., and Cochran N. Novel fucolipids accumulating in human adenocarcinoma: II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J. Biol. Chem. 259 (1984) 4681-4685
11. 6). J. Biol. Chem. 259 (1984) 10511-10517
12. Nudelman E., Levery S.B., Kaizu T., and Hakomori S. Novel fucolipids of human adenocarcinoma: Characterization of the major Ley antigen of human adenocarcinoma as trifucosylnonaosyl Ley glycolipid (III3FucV3FucVI2FucnLc6). J. Biol. Chem. 261 (1986) 11247-11253
13. 4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J. Biol. Chem. 261 (1986) 5487-5495
14. Ohara K., Sano M., Kondo A., and Kato I. Two-dimensional mapping by high-performance liquid chromatography of pyridylamino oligosaccharides from various glycosphingolipids. J. Chromatogr. 586 (1991) 35-41
15. Fukushi Y., Nudelman E., Levery S.B., Higuchi T., and Hakomori S. A novel disialoganglioside (IV3NeuAcIII6NeuAcLc4) of human adenocarcinoma and the monoclonal antibody (FH9) defining this disialosyl structure. Biochemistry 25 (1986) 2859-2866
16. Ito M., and Yamagata T. Purification and characterization of glycosphingolipid-specific endoglycosidases (endoglycoceramidases) from a mutant strain of Rhodococcus sp.: Evidence for three molecular species of endoglycoceramidase with different specificities. J. Biol. Chem. 264 (1989) 9510-9519
17. Natsuka S., and Hase S. Analysis of N- and O-glycans by pyridylamination. Methods Mol. Biol. 76 (1998) 101-113
18. Tokugawa K., Oguri S., and Takeuchi M. Large scale preparation of PA-oligosaccharides from glycoproteins using an improved extraction method. Glycoconj. J. 13 (1996) 53-56
19. Harvey D.J., Mattu T.S., Wormald M.R., Royle L., Dwek R.A., and Rudd P.M. "Internal residue loss": Rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus. Anal. Chem. 74 (2002) 734-740
20. Wuhrer M., Kantelhardt S.R., Dennis R.D., Doenhoff M.J., Lochnit G., and Geyer R. Characterization of glycosphingolipids from Schistosoma mansoni eggs carrying Fuc(α1-3)GalNAc-, GalNAc(β1-4)[Fuc(α1-3)]GlcNAc- and Gal(β1-4)[Fuc(α1-3)]GlcNAc- (Lewis X) terminal structures. Eur. J. Biochem. 269 (2002) 481-493
21. Watanabe K., Powell M.E., and Hakomori S.I. Isolation and characterization of gangliosides with a new sialosyl linkage and core structures: II. Gangliosides of human erythrocyte membranes. J. Biol. Chem. 254 (1979) 8223-8229
22. Kameyama A., Kikuchi N., Nakaya S., Ito H., Sato T., Shikanai T., Takahashi Y., Takahashi K., and Narimatsu H. A strategy for identification of oligosaccharide structures using observational multistage mass spectral library. Anal. Chem. 77 (2005) 4719-4725
23. Kameyama A., Nakaya S., Ito H., Kikuchi N., Angata T., Nakamura M., Ishida H.K., and Narimatsu H. Strategy for simulation of CID spectra of N-linked oligosaccharides toward glycomics. J. Proteome Res. 5 (2006) 808-814
24. Grundmann U., Nerlich C., Rein T., and Zettlmeissl G. Complete cDNA sequence encoding human β-galactoside α-2,6-sialyltransferase. Nucleic Acids Res. 18 (1990) 667
25. Takashima S., Tsuji S., and Tsujimoto M. Characterization of the second type of human β-galactoside α-2,6-sialyltransferase (ST6Gal II), which sialylates Galβ1,4GlcNAc structures on oligosaccharides preferentially: Genomic analysis of human sialyltransferase genes. J. Biol. Chem. 277 (2002) 45719-45728
26. Oriol R., and Mollicone R. α2-Fucosyltransferases (FUT1, FUT2, and Sec1). In: Taniguchi N., Honke K., and Fukuda M. (Eds). Handbook of Glycosyltransferases and Related Genes (2002), Springer, Tokyo 205-217